Bamate and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Bamate (meprobamate), especially for people who are female, 60+ old, also take Lipitor, and have Pain.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Bamate. It is created by eHealthMe based on reports of 2,243 people who have side effects when taking Bamate from the FDA, and is updated regularly.

What is Bamate?

Bamate has active ingredients of meprobamate. eHealthMe is studying from 2,268 Bamate users. Check the latest studies of Bamate.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,524 drugs and 4,592 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 05, 2026

2,243 people reported to have side effects when taking Bamate.
Among them, 17 people (0.76%) have Appetite - decreased.

Could Bamate cause Appetite - decreased?

Among these 17 people:

What is the gender of people who have Appetite - decreased when taking Bamate? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Appetite - decreased when taking Bamate? *

What are other drugs people take besides Bamate? *

What are other side effects people have besides Appetite - decreased? *

Headache (pain in head): 6 people, 35.29%
Weakness: 6 people, 35.29%
Pain: 6 people, 35.29%
Confusional State: 6 people, 35.29%
Chest Pain: 5 people, 29.41%
Fatigue (feeling of tiredness): 5 people, 29.41%
Agitation (state of anxiety or nervous excitement): 5 people, 29.41%
Inflammation: 5 people, 29.41%
Dyspnea (difficult or laboured breathing): 5 people, 29.41%
Arrhythmias (irregular heartbeat): 5 people, 29.41%

What are the existing conditions these people have? *

Pain: 3 people, 17.65%
Blood Pressure Abnormal: 2 people, 11.76%
Ill-Defined Disorder: 2 people, 11.76%
Stress And Anxiety: 2 people, 11.76%
Type 2 Diabetes: 1 person, 5.88%
Dyslipidaemia (abnormal amount of lipids): 1 person, 5.88%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 5.88%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%
Colon Cancer: 1 person, 5.88%
Depression: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bamate and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bamate:

Bamate (2,268 reports)

Browse all side effects of Bamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,524 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,592 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on meprobamate (the active ingredients of Bamate) and Bamate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.